Arrowhead Pharmaceuticals Newsroom

H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $80

Futu NewsDec 21 03:31

Arrowhead Pharmaceuticals Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow JonesDec 21 00:13

Arrowhead Pharma Analyst Ratings

BenzingaDec 21 00:04

B.Riley Financial Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Announces Target Price $51

Futu NewsDec 12 21:31

B. Riley Lowers Price Target on Arrowhead Pharmaceuticals to $51 From $55, Keeps Buy Rating

MT NewswiresDec 12 20:55

Chardan Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $60

Futu NewsDec 12 10:31

Promising Clinical Trial Results Boost Confidence in Arrowhead Pharmaceuticals, Justifying Buy Rating

TipRanksDec 12 10:17

Piper Sandler Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $45

Futu NewsDec 6 00:35

Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Heron Therapeutics (HRTX)

TipRanksDec 6 00:18

Arrowhead Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow JonesDec 4 01:17

Arrowhead Pharmaceuticals Price Target Raised to $80.00/Share From $60.00 by HC Wainwright & Co.

Dow JonesDec 4 01:17

Arrowhead Pharma Analyst Ratings

BenzingaDec 4 01:07

Bernstein Maintains Market Perform on Arrowhead Pharma, Lowers Price Target to $24

BenzingaNov 29 21:36

Analysts' Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR) and Sanofi (OtherSNYNF)

TipRanksNov 29 11:24

Arrowhead Pharmaceuticals Is Maintained at Neutral by Citigroup

Dow JonesNov 27 23:34

RBC Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $42

Futu NewsNov 27 21:32

Piper Sandler Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Cuts Target Price to $45

Futu NewsNov 27 21:32

A Quick Look at Today's Ratings for Arrowhead Pharmaceuticals(ARWR.US), With a Forecast Between $26 to $45

Futu NewsNov 27 21:02

Arrowhead Pharma Analyst Ratings

BenzingaNov 27 20:29

Chardan Capital Maintains Buy on Arrowhead Pharma, Maintains $60 Price Target

BenzingaNov 27 20:29